苏金单抗减轻蛛网膜下腔出血诱导的氧化损伤
该研究在40只雄性Wistar白化大鼠中分为对照组、SEC组、SAH组和SAH+SEC组,通过枕骨大孔注射自体血诱导SAH,术后每周一次腹腔注射SEC,第14天取脑组织行生化与组织病理检查。结果显示SEC(3 mg/kg)显著降低丙二醛水平并升高超氧化物歧化酶、谷胱甘肽、过氧化氢酶和谷胱甘肽过氧化物酶水平,同时减轻组织病理学改变;作者认为SEC具有抗氧化和神经保护特性,但需进一步高级研究证明其对人类的潜在益处。
要点
- SAH可升高丙二醛并降低超氧化物歧化酶、谷胱甘肽、过氧化氢酶和谷胱甘肽过氧化物酶水平。
- SEC(3 mg/kg)显著降低丙二醛并升高上述抗氧化酶水平,减轻脑组织组织病理学改变。
- 作者认为SEC具有抗氧化和神经保护特性,但需进一步高级研究证明其对人类的潜在益处。
核心结论
- SEC(3 mg/kg)对实验性SAH引起的血液参数和脑组织氧化及组织病理学改变有治疗性影响,可减轻SAH大鼠脑损伤,具有抗氧化和神经保护特性,但需进一步高级研究证明其对人类的潜在益处。
研究设计与样本
- 研究为动物实验,使用40只雄性Wistar白化大鼠随机均分为4组:对照组、SEC组、SAH组和SAH+SEC组。
- SAH组和SAH+SEC组通过枕骨大孔向蛛网膜下腔注射从大鼠心脏采集的自体血诱导SAH。
- SEC组和SAH+SEC组在手术后每周一次腹腔注射SEC,第14天处死大鼠取脑组织行生化分析和组织病理学检查。
主要发现
- SAH导致氧化应激参数改变:丙二醛水平升高,超氧化物歧化酶、谷胱甘肽、过氧化氢酶和谷胱甘肽过氧化物酶水平降低。
- SAH组脑组织组织病理学显示充血和细胞浸润等改变。
- SEC治疗显著降低丙二醛水平并升高超氧化物歧化酶、谷胱甘肽、过氧化氢酶和谷胱甘肽过氧化物酶水平,同时减轻脑组织组织病理学改变。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文指出需进一步高级研究证明SEC对人类的潜在益处。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: This study aimed to investigate the histological and biochemical neuroprotective effects of secukinumab (SEC) on brain damage induced by subarachnoid hemorrhage (SAH) in male Wistar Albino rats. METHODS: Forty male Wistar Albino rats were randomly divided into 4 groups of equal size: control, SEC, SAH, and SAH + SEC. SAH was induced the SAH and SAH + SEC groups by injecting autologous blood collected from the hearts of the rats into the subarachnoid space via the foramen magnum. SEC was administered intraperitoneally once a week to the SEC and SAH + SEC groups after the surgical procedure. On the 14th day of surgery, the rats were sacrificed and their cerebral tissues were collected for biochemical analysis and histopathological examination. RESULTS: SAH led to changes in oxidative stress parameters by increasing malondialdehyde levels and decreasing superoxide dismutase, glutathione, catalase, and glutathione peroxidase levels. Histopathologically, cerebral tissues in the SAH groups showed alterations such as congestion and cell infiltration. Treatment with SEC significantly reduced malondialdehyde levels and increased superoxide dismutase, glutathione, catalase, and glutathione peroxidase levels. SEC also decreased histopathological alterations in brain tissues. CONCLUSIONS: This study revealed that SEC (3 mg/kg) therapeutically influenced oxidative and histopathological changes in blood parameters and brain tissues caused by experimental SAH. SEC helps reduce brain damage in rats with SAH and possesses antioxidant and neuroprotective properties. Further advanced studies are needed to prove its potential benefits for humans.
引用
- Kiyak V, Gevrek F, Demir O, et al. Secukinumab Ameliorates Oxidative Damage Induced by Subarachnoid Hemorrhage. World Neurosurg. 2024. PMID: 39154958. doi:10.1016/j.wneu.2024.07.080
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。